Development of a reaction-limited model of dissolution: Application to official dissolution tests experiments

International Journal of Pharmaceutics

Volumn 355, Issue 1-2, 2008, Pages 114-125

  Dokoumetzidis, A ^a   Papadopoulou, V ^b   Valsami, G ^b   Macheras, P ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Dissolution; Dissolution tests; Reaction limited model; Solubility

Indexed keywords

FUROLIN; NAPROXEN; NITROFURANTOIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG SOLUBILITY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PRIORITY JOURNAL; TABLET FORMULATION;

ALGORITHMS; ANTI-INFECTIVE AGENTS, URINARY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MODELS, CHEMICAL; NAPROXEN; NITROFURANTOIN; REFERENCE STANDARDS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 41349116109     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.11.056     Document Type: Article

References (50)

1. Atkinson A.C., and Donev A.N. Optimum Experimental Designs (1992), Clarendon Press, Oxford
2. Bakatselou V., Oppenheim R.C., and Dressman J.B. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm. Res. 8 (1991) 1461-1469
3. Brunner E. Reaktionsgeschwindigkeit in heterogenen Systemen. Z. Phys. Chem. 43 (1904) 56-102
4. Crison J.R., Shah V.P., Skelly J.P., and Amidon G.L. Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine. J. Pharm. Sci. 85 (1996) 1005-1011
5. D'Arcy D.M., Corrigan O.I., and Healy A.M. Hydrodynamic simulation (CFD) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability. J. Pharm. Pharmacol. 57 (2005) 1243-1250
6. Daccord G. Dissolutions, evaporations, etchings. In: Avnir D. (Ed). The Fractal Approach to Heterogeneous Chemistry (1989), John Willey & Sons, Chichester 183-197
7. D'Arcy D.M., Corrigan O.I., and Healy A.M. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics-dissolution rate implications. Eur. J. Pharm. Sci. 27 (2006) 259-267
8. Dejmek M., and Ward C.A. A statistical rate theory study of interface concentration during crystal growth or dissolution. J. Chem. Phys. 108 (1998) 8698-8704
9. Dokoumetzidis A., and Macheras P. A population growth model of dissolution. Pharm. Res. 14 (1997) 1122-1126
10. Dokoumetzidis A., and Macheras P. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int. J. Pharmaceut. 321 (2006) 1-11
11. Dokoumetzidis A., Papadopoulou V., and Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. Pharm. Res. 23 (2006) 256-261
12. Farin D., and Avnir D. Use of fractal geometry to determine effects of surface morphology on drug dissolution. J. Pharm. Sci. 81 (1992) 54-57
13. FDA, 2000. Guidance for Industry, Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system. FDA/CDER, Washington D.C.
14. Greenberg J., and Tomson M. Precipitation and dissolution kinetics and equilibria of aqueous ferrous carbonate vs. temperature. Appl. Geochem. 7 (1992) 185-190
15. Higuchi W.I. Diffusional models useful in biopharmaceutics. J. Pharm. Sci. 56 (1967) 315-324
16. 4 crystal with ion selective electrode. Chem. Eng. Sci. 56 (2001) 7017-7024
17. Jinno J., Oh D., Crison J.R., and Amidon G.L. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J. Pharm. Sci. 89 (2000) 268-274
18. Khoury N., Mauger J.W., and Howard S. Dissolution rate studies from a stationary disk/rotating fluid system. Pharm. Res. 5 (1988) 495-500
19. Kimura M., Djilali N., and Dost S. Convective transport and interface kinetics in liquid phase epitaxy. J. Cryst. Growth. 143 (1994) 334-348
20. Lansky P., and Weiss M. Does the dose-solubility ratio affect the mean dissolution time of drugs?. Pharm. Res. 16 (1999) 1470-1476
21. Lansky P., and Weiss M. Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity. J. Pharm. Sci. 92 (2003) 1632-1647
22. Levich V. Physicochemical Hydrodynamics (1962), Prentice Hall, Englewood Cliffs, NJ
23. Lin H., Rosenberger F., Alexander J.I.D., and Nadarajah A. Convective-diffusive transport in protein crystal growth. J. Cryst. Growth 151 (1995) 153-162
24. Macheras P., and Argyrakis P. Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity?. Pharm. Res. 14 (1997) 842-847
25. Macheras P., and Dokoumetzidis A. On the heterogeneity of drug dissolution and release. Pharm. Res. 17 (2000) 108-112
26. Macheras P., and Iliadis A. Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches (2006), Springer, New York
27. McCarthy L.G., Bradley G., Sexton J.C., Corrigan O.I., and Healy A.M. Computational fluid dynamics modelling of the paddle dissolution apparatus: agitation rate, mixing patterns and fluid velocities. AAPS PharmSciTech. (2004) 5 Article 31
28. McCarthy L.G., Kosiol C., Healy A.M., Bradley G., Sexton J.C., and Corrigan O.I. Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus. AAPS PharmSciTech. (2003) 4 Article 22
29. Miller-Chou B.A., and Koenig J.L. A review of polymer dissolution. Prog. Polym. Sci. 28 (2003) 1223-1270
30. Missel P.J., Stevens L.E., and Mauger J.W. Dissolution of anecortave acetate in a cylindrical flow cell: Re-evaluation of convective diffusion/drug dissolution for sparingly soluble drugs. Pharm. Drug Dev. Technol. 9 (2004) 453-459
31. Missel P.J., Stevens L.E., and Mauger J.W. Re-examination of convective diffusion/drug dissolution in a laminar flow channel: accurate prediction of dissolution rate. Pharm. Res. 12 (2004) 2300-2306
32. Naylor L.J., Bakatselou V., Rodriguez-Hornedo N., Weiner N.D., and Dressman J.B. Dissolution of steroids in bile salt solutions is modified by the presence of lecithin. Eur. J. Pharm. Biopharm. 41 (1995) 346-353
33. Nedich R.L., and Kildsig D.O. Mechanism of dissolution. I. Mathematical interpretation of concentration gradients developed during dissolution of a solid. J. Pharm. Sci. 61 (1972) 214-218
34. Nernst W. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen. Z. Phys. Chem. 47 (1904) 52-55
35. Nicklasson M., Brodin A., and Nyqvist H. Studies on the relationship between solubility and intrinsic rate of dissolution as a function of pH. Acta Pharm. Suec. 18 (1981) 119-128
36. Nicklasson M., Brodin A., and Sundelöf L.O. On the determination of true dissolution rate parameters from rotating disc experiments. Int. J. Pharm. 15 (1983) 87-95
37. Noyes A.A., and Whitney W.R. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 19 (1897) 930-934
38. Persson E.M., Gustafsson A.S., Carlsson A.S., Nilsson R.G., Knutson L., Forsell P., Hanisch G., Lennernas H., and Abrahamsson B. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm. Res. 22 (2005) 2141-2151
39. Robertson E.A., and Fogler H.S. Model for the reaction-rate-limited dissolution of solids with etch-rate heterogeneities. AICHE J. 42 (1996) 2654-2660
40. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug. Deliv. Rev. 48 (2001) 139-157
41. Sunagawa I., Tsukamoto K., Maiwa K., and Onuma K. Growth and perfection of crystals from aqueous solution: case studies on barium nitrate and Kalum. Prog. Cryst. Growth Charact. Mater. 30 (1995) 153-190
42. Swarbrick J. In vitro models of drug dissolution. In: Swarbrick J. (Ed). Current Concepts in the Pharmaceutical Sciences: Biopharmaceutics (1970), Lea & Febiger, Philadelphia 265-296
43. Tao J.C., Cussler E.L., and Evans D.F. Accelerating gallstone dissolution. Proc. Nat. Acad. Sci. 71 (1974) 3917-3921
44. Touitou E., and Donbrow M. Deviation of dissolution behavior of benzoic-acid from theoretical predictions with lowering of temperature-Limitations as a model dissolution substance. Int J. Pharmaceut. 9 (1981) 97-106
45. USP, 2006, USP 29 - NF 24. Official Monographs for Naproxen, Nitrofurantoin.
46. Valsami G., and Macheras P. Determination of fractal reaction dimension in dissolution studies. Eur. J. Pharm. Sci. 3 (1995) 163-169
47. Wagner J. Biopharmaceutics: absorption aspects. J. Pharm. Sci. 50 (1961) 359-386
48. Weitschies W., Kosch O., Monnikes H., and Trahms L. Magnetic marker monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug. Deliv. Rev. 57 (2005) 1210-1222
49. Wurster D.E., and Taylor P.W. Dissolution rates. J. Pharm. Sci. 54 (1965) 169-175
50. Yang C.F., and Cussler E.L. Oxygen barriers that use free radical chemistry. AICHE J. 47 (2001) 2725-2732